BioStrand Omics Analysis Blog:
Multi-Omics

AI-powered genomics to advance precision medicine

Dr Ingrid Brands, CEO | July 27, 2022

Sir William Osler, often called the father of modern medicine, was among the first to articulate a ...

AI, NLP and the ROI of drug development

Dr Ingrid Brands, CEO | July 20, 2022

The out-of-pocket R&D costs of developing a single drug, whether successfully launched or not, are...

Accelerating pharma R&D and innovation through technology partnerships

Dr Ingrid Brands, CEO | July 13, 2022

Biopharmas are increasingly turning to alliances & partnerships to drive external innovation....

Functional multiomics and antibody discovery

Dr Ingrid Brands, CEO | July 6, 2022

Genomics is the forerunner of all omics technologies, first introduced in 1987 as the name of a new...

Challenges In Multi-Omics Data Integration

Dr Ingrid Brands, CEO | February 9, 2022

Today, the integrative computational analysis of multi-omics data has become a central tenet of the...

Subscribe to our blog

The transformative power of text in multi-omics analysis

Dr Ingrid Brands, CEO | February 2, 2022

Sequence comparison, a fundamental and critical component of modern molecular biological research,...

The evolution of bioinformatics

Dr Ingrid Brands, CEO | January 12, 2022

Conventional vaccine development, still based predominantly on systems developed in the last century

The role of NGS in breast cancer diagnosis and treatment

Dr Ingrid Brands, CEO | October 21, 2021

Breast cancer is the most common cancer in women worldwide, accounting for 25% of all female...

The metadata challenge in biological research

Dr Ingrid Brands, CEO | October 12, 2021

One of the key highlights of the global response to COVID-19 has been the importance of effective,...

Learnings from the global response to the pandemic

Dr Ingrid Brands, CEO | September 30, 2021

Prior to 2020, the fastest vaccine development program had taken four years from viral sampling to...

The future of precision medicine

Dr Ingrid Brands, CEO | September 16, 2021

The sequencing of the human genome heralded a potential revolution in healthcare. So much so that...